Table 1 Phenotypic drug susceptibility test for V. vulnificus strains
Antibiotic class | Drugs | Environment (n = 8) | Clinical (n = 14) | ||||
|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | ||
Fluoroquinolones | CIP | 8 (100%) | 0 | 0 | 14 (100%) | 0 | 0 |
Cephalosporins | FOX | 4 (50)% | 2 (25%) | 2 (25%) | 9 (64.3%) | 3 (21.4%) | 2 (14.3%) |
FEP | 7 (87.5%) | 0 | 1 (12.5%) | 9 (64.3%) | 0 | 5 (35.7%) | |
Amphenicols | CHL | 8 (100%) | 0 | 0 | 13 (92.9%) | 0 | 1 (7.1%) |
Aminoglycosides | GEN | 8 (100%) | 0 | 0 | 14 (100%) | 0 | 0 |
Tetracyclines | TET | 8 (100%) | 0 | 0 | 14 (100%) | 0 | 0 |
Quinolones | NAL | 8 (100%) | 0 | 0 | 14 (100%) | 0 | 0 |
Cephems | CAZ | 7 (87.5%) | 0 | 1 (12.5%) | 10 (71.4%) | 0 | 4 (28.6%) |
CTX | 5 (62.5%) | 0 | 3 (37.5%) | 12 (85.7%) | 0 | 2 (14.3%) | |
Carbapenem | MEM | 7 (87.5%) | 0 | 1 (12.5%) | 10 (71.4%) | 0 | 4 (28.6%) |
Penicillin | AMP | 7 (87.5%) | 0 | 1 (12.5%) | 13 (92.9%) | 0 | 1 (7.1%) |
AMC | 7 (87.5%) | 0 | 1 (12.5%) | 14 (100%) | 0 | 0 | |
Polymyxin | COL | 0 | 1 (12.5%) | 7 (87.5%) | 0 | 3 (21.4%) | 11 (78.6%) |
Sulfonamide | FIS | 8 (100%) | 0 | 0 | 14 (100%) | 0 | 0 |
SXT | 5 (62.5%) | 0 | 3 (37.5%) | 11 (78.6%) | 0 | 3 (21.4%) | |